Drug Trials Working on Slowing the Progress of Alzheimer’s Disease

A recent study shows there is new evidence that resveratrol (found in grapes, blueberries, raspberries, and dark chocolate) may slow the progress of Alzheimer’s disease. You can read more about this research being done at the Georgetown University Medical Center.

Another study that is going into its “phase-three trial” in 2016 is in regards to the drug solanezumab. This drug has shown that it holds off memory loss in people who have mild Alzheimer’s disease. What I found most interesting about this article (“Scientists Find First Drug That Appears to Slow Alzheimer’s disease”) is that “between 2002 and 2012, 99.6% of drugs studies aimed at preventing, curing or improving Alzheimer’s symptoms were either halted or discontinued at huge financial cost to drugs companies, many of whom shut down dementia programmes as a result.” That is disheartening to hear, but at least drug trials are still going on; unfortunately, not as many as needed to cure this disease.

The amount of people who volunteer to be a part of these trials in United Kingdom has grown, which is a good thing because they are “essential to our battle against the disease.”

I appreciate the scientists, doctors, and volunteers who get involved in these drug trials because it means there is a chance a cure will be found.

Related Posts

Comments are closed.